EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2

The guidelines summarize the current views of
the European Association of Nuclear Medicine Neuroimaging
Committee (ENC). The aims of the guidelines are
to assist nuclear medicine practitioners in making recommendations,
performing, interpreting and reporting the
results of clinical dopamine D2 receptor SPECT or PET
studies, and to achieve a high quality standard of dopamine
D2 receptor imaging, which will increase the impact of this
technique in neurological practice.
The present document is an update of the first
guidelines for SPECT using D2 receptor ligands labelled
with 123I [1] and was guided by the views of the Society
of Nuclear Medicine Brain Imaging Council [2], and the
individual experience of experts in European countries.
The guidelines intend to present information specifically
adapted to European practice. The information provided
should be taken in the context of local conditions and
regulations.